Venetoclax combined with three-day multi-frequency decitabine (DEC3-VEN) in elder or intensive chemotherapy ineligible patients with newly diagnosed acute myeloid leukemia

Blood Cancer J. 2024 Nov 20;14(1):204. doi: 10.1038/s41408-024-01189-2.
No abstract available

Publication types

  • Letter